secwatch.observer — SEC 8-K summary
======================================

Issuer:     HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK:        0000818033
Form:       8-K
Filed at:   2023-12-21T23:59:59+00:00
Accession:  0001193125-23-301337
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Kevin Kotler resigns from Heron Therapeutics board effective Dec 31, 2023
--------------------------------------------------------------------------------

- Kevin Kotler resigned from the Board, effective December 31, 2023.
- Resignation not due to any disagreements with the company's operations, policies or practices.
- No replacement named at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818033/000119312523301337/0001193125-23-301337-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818033/000119312523301337/d96206d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-301337

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer